Labopharm receives US FDA nod for Oleptro to treat depressive disorder
Friday, February 05, 2010 10:00 IST Princeton, New Jersey
Labopharm Inc announced the US Food and Drug Administration (FDA) has approved Oleptro (trazodone hydrochloride) Extended Release tablets, a novel once-daily formulation of the antidepressant trazodone